ferumoxsil

Subscribe to Selected New Research on ferumoxsil

5 relevant articles (2 outcomes, 1 trials/studies) found for this Drug

Description: a large superparamagnetic iron oxide colloid; a miscible darkening agent; see also the dextran-coated superparamagnetic iron oxides - ferumoxides and ferumoxtran

Also Known As:

AMI 121; AMI-121; Gastromark; Lumirem; siloxane-coated SPIO; siloxane-coated superparamagnetic iron oxide

Relationship Network

Drug Context: Research Results

Related Diseases

1.	Female Genital Diseases 07/01/1995 - "The purpose of this study was to determine the tolerance and the efficacy of the oral contrast agent ferumoxsil in the assessment of gynecologic diseases. " 07/01/1995 - "Oral superparamagnetic contrast agent (ferumoxsil): tolerance and efficacy in MR imaging of gynecologic diseases." Order ALL the reference details at left...
2.	Neoplasms (Cancer) 02/01/1996 - "In a phase III clinical trial we have determined the safety and efficacy of Lumirem in the assessment of gynecological neoplasms. " 11/01/1997 - "Twenty patients with suspected rectosigmoid and ovarian tumors were prospectively examined before and after rectal administration of 300 to 600 ml of the superparamagnetic contrast agent Ferumoxsil. " Order ALL the reference details at left...
3.	Rectal Neoplasms (Rectal Cancer) 01/01/2008 - "MATERIALS AND METHODS: 37 consecutive patients with rectal cancer were imaged using a mixture of ferumoxsil and methylcellulose endorectally, and a gadolinium contrast intravenously. " Order ALL the reference details at left...
4.	Polyps 05/01/2008 - "MRC found 1 of 22 (5%) polyps <6 mm, 2 of 3 (67%) polyps 6-10 mm, and 2 of 2 (100%) polyps >10 mm. CONCLUSION: MRC with fecal tagging using barium sulfate/ferumoxsil as contrast agent will give better overall assessment of the colon wall compared to barium sulfate alone. " Order ALL the reference details at left...

Related Drugs and Biologics

1.	Methylcellulose (BFL)
2.	Gadolinium
3.	Barium Sulfate (Barite)

Related Therapies and Procedures

1.	Rectal Administration

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>